Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksei A Stepanenko

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Pharmacology|January 27, 2022
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord InjuryAnastasiia O Sosnovtseva, Olga V Stepanova, Aleksei A Stepanenko, et al.
International Journal of Molecular Sciences|May 7, 2025
Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic TransgenesAleksei A Stepanenko, Anastasiia O Sosnovtseva, Marat P Valikhov, et al.
Molecular Therapy Oncolytics|January 24, 2022
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma culturesAleksei A Stepanenko, Anastasiia O Sosnovtseva, Marat P Valikhov, et al.
Biomedicines|July 27, 2022
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver CellsVictor A Naumenko, Daniil A Vishnevskiy, Aleksei A Stepanenko, et al.
Stem Cells and Development|December 1, 2021
Study of the Therapeutic Efficiency of Transduced Olfactory Ensheathing Cells in Spinal Cord CystsOlga V Stepanova, Anastasia D Voronova, Anastasiia O Sosnovtseva, et al.
Cancer Cell International|May 10, 2016
Temozolomide promotes genomic and phenotypic changes in glioblastoma cellsAleksei A Stepanenko, Svitlana V Andreieva, Kateryna V Korets, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Pharmacology|January 27, 2022
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord InjuryAnastasiia O Sosnovtseva, Olga V Stepanova, Aleksei A Stepanenko, et al.
International Journal of Molecular Sciences|May 7, 2025
Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic TransgenesAleksei A Stepanenko, Anastasiia O Sosnovtseva, Marat P Valikhov, et al.
Molecular Therapy Oncolytics|January 24, 2022
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma culturesAleksei A Stepanenko, Anastasiia O Sosnovtseva, Marat P Valikhov, et al.
Biomedicines|July 27, 2022
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver CellsVictor A Naumenko, Daniil A Vishnevskiy, Aleksei A Stepanenko, et al.
Stem Cells and Development|December 1, 2021
Study of the Therapeutic Efficiency of Transduced Olfactory Ensheathing Cells in Spinal Cord CystsOlga V Stepanova, Anastasia D Voronova, Anastasiia O Sosnovtseva, et al.
Cancer Cell International|May 10, 2016
Temozolomide promotes genomic and phenotypic changes in glioblastoma cellsAleksei A Stepanenko, Svitlana V Andreieva, Kateryna V Korets, et al.
Pageof 2